Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers.

AUTOR(ES)

Gonzalez, M A

RESUMO

We administered multiple doses of ciprofloxacin intravenously over 30 min every 12 h for 1 week to nine healthy volunteers. Three volunteers received a placebo (vehicle) intravenously. Doses of 100, 150, and 200 mg were evaluated with a 1-week wash-out period intervening between each dose level. Terminal excretion half-lives averaged 3.67 +/- 0.65, 3.60 +/- 0.26, and 4.00 +/- 0.69 h for the 100-, 150-, and 200-mg doses, respectively. Serum clearances were 30.1 +/- 3.4, 29.8 +/- 4.0, and 26.9 +/- 4.1 liters/h per 1.73 m2 for these doses. Urine concentrations remained in excess of the MIC for 90% of the relevant urinary tract pathogens for the full 12-h dosing interval at each dose. Renal clearance accounted for 56 to 71% of the serum clearance. However, because a microbiologic assay was used and biologically active, renally excreted metabolites were identified, the renal clearance determinations are likely to be in excess of the true values. The doses of ciprofloxacin administered intravenously were well tolerated, and the drug concentrations appeared adequate for the treatment of the vast majority of cases of nosocomially acquired sepsis and urinary tract infections. For patients with serious Pseudomonas infections and perhaps staphylococcal infections, either an 8-h dosing schedule or larger doses on a 12-h schedule should be considered.

Documentos Relacionados

• Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
• Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
• Comparative pharmacokinetics of two multiple-dose mezlocillin regimens in normal volunteers.
• Multiple-dose pharmacokinetics of ceftibuten in healthy volunteers.
• Multiple-dose pharmacokinetics of amdinocillin in healthy volunteers.